Medicine and Dentistry
Connective Tissue Cancer
100%
Hypoxia
65%
Soft Tissue Sarcoma
54%
Hypoxia Inducible Factor 1
46%
Rhabdomyosarcoma
45%
Neoplasm
42%
Metastatic Carcinoma
33%
Malignant Neoplasm
33%
Tumor Cell
30%
Targeted Therapy
28%
Gene Expression
25%
Ischemia
24%
Diseases
23%
Hypoxia Inducible Factor 1beta
22%
Ganglioneuroblastoma
22%
Fibroblast
22%
Ribociclib
22%
Gastrointestinal Stromal Tumor
22%
Glioblastoma
22%
Leukocyte
22%
Glutamine
22%
Hematopoietic Cell
22%
Carcinogenesis
22%
Vascular Bundle
22%
Autophagy
22%
Systemic Therapy
22%
Cell Cycle Arrest
22%
Cell Cycle Checkpoint
22%
Next Generation Sequencing
22%
Immune Checkpoint Blockade
22%
microRNA 124
22%
Succinate Dehydrogenase
22%
Hepatocellular Carcinoma
22%
Leiomyosarcoma
22%
Tumor Microenvironment
22%
Cell Viability
22%
Vasculotropin
22%
Immunity
22%
Cell Signaling Pathway
22%
Disease Exacerbation
22%
Procollagen Lysine 2 Oxoglutarate 5 Dioxygenase
22%
Hypoxia Inducible Factor
17%
Xenograft
15%
Doxorubicin
14%
Embolization
12%
Molecular Profiling
11%
Imatinib
11%
Tumor Progression
11%
Pediatrics
10%
Carcinoma Cell
10%
Keyphrases
Soft Tissue Sarcoma
57%
Hypoxia
45%
Leiomyosarcoma
45%
Hypoxia-inducible factor-1α (HIF-1α)
40%
Sarcoma
36%
Targeted Therapy
27%
DNA Damage Response
27%
Clinical Characteristics
27%
Forkhead Box M1 (FOXM1)
26%
Vascular Endothelial Growth Factor
25%
MD Anderson Cancer Center
25%
Autophagy
22%
Aryl Hydrocarbon Receptor
22%
Single Institution
22%
LEE011
22%
Ischemia
22%
MYC Protein
22%
Deregulation
22%
Cyclin-dependent Kinase 6 (CDK6)
22%
Quiescence
22%
DNA Repair Genes
22%
Cyclin-dependent Kinase 4 (CDK4)
22%
Hematopoietic Stem Cells
22%
Pharmacologic
22%
Stem Cell Viability
22%
Center Experience
22%
Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2
22%
Immune Checkpoint Blockade
22%
Metabolic Adaptation
22%
Induced Cell Death
22%
Cell Cycle Arrest
22%
Gastrointestinal Stomal Tumors
22%
Evasive Resistance
22%
Hepatocellular Carcinoma
22%
RNase H2
22%
Clinical Outcomes
22%
Hippo Pathway
22%
Murine Hematopoietic Stem Cells
22%
First-line Systemic Therapy
22%
Re-expression
22%
Alveolar Rhabdomyosarcoma
22%
Pleomorphic Sarcoma
22%
Oxygen Availability
22%
Neuroblastoma
22%
HIF-2
22%
Epigenetics
22%
Senescence
22%
Tumorigenesis
22%
Undifferentiated Pleomorphic Sarcoma
20%
Transarterial Embolization
18%
Biochemistry, Genetics and Molecular Biology
Hypoxia Inducible Factor 1
46%
Cell Survival
45%
DNA Damage Response
45%
Cell Death
33%
Genetics
33%
Cell Proliferation
26%
Next Generation Sequencing
24%
Aryl Hydrocarbon Receptor Nuclear Translocator
22%
Macrophage
22%
Wild Type
22%
Fibroblast
22%
Leukocyte
22%
Carcinogenesis
22%
Epigenetics
22%
Gene Expression
22%
Dioxygenase
22%
DNA Repair
22%
Lipid
22%
Platelet Derived Growth Factor Receptor Alpha
22%
Cell Viability
22%
Hematopoietic Cell
22%
Glutamine
22%
Mammalian Target of Rapamycin
22%
Ribonuclease
22%
Vascular Endothelial Growth Factor
22%
Lysine
22%
Imatinib
22%
Fumarate Reductase
22%
MicroRNA
22%
Succinate Dehydrogenase
22%
Telomere
22%
Genomics
19%
Hypoxia-Inducible Factors
17%
Loss of Function Mutation
16%
Tumor Volume
13%
RNA Polymerase III
11%
Proteolysis
11%
Cathepsin
11%
Keratinocyte
11%
Cell Cycle Progression
11%
Forkhead Transcription Factor
11%
Cell Metabolism
11%
Cathepsin S
11%
FBXW7
11%
Mouse Model
11%
DDB1
11%
Ubiquitin-Conjugating Enzyme
11%
Colon
11%
Cathepsin D
11%
Tumor Progression
10%
